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Pueraria mirifica (PM) has traditionally been used to relieve postmenopausal 
symptoms. Recently, its extract has been developed into various cosmetic 
products to promote skin rejuvenation and youthfulness. This study 
investigated the phytochemicals of PM tuber and compared between the 
tuber flesh and its outer peel. Puerarin which is one of the major isoflavones 
and being considered as the marker compound was used to determine 
the presence of PM extract in local cosmetic products. Puerarin could be 
ionized by a mass spectrometer at both negative and positive modes. The 
peak ionized at the negative mode showed to have a narrower peak width 
(0.2 min) and higher signal-to-noise ratio (30) for pueararin (1 mg/L). 
The results also found PM extract contained many C- and O-glycosylated 
isoflavones, especially from its peel extract. This explains the peel extract 
showed to have four times higher antiradical activity than those of flesh 
extract. Puerarin from the cosmetic products was recovered via successive 
methanolic sonication and followed by liquid-liquid extraction using ethyl 
acetate. Puerarin was successfully partitioned from the highly complex 
chemical mixture of cosmetic products with the recovery ranged from 
89.1 % to 115 %. Hence, isoflavones was found to be higher at the outer 
peels than its tuber flesh. A simple and reliable method has been developed 
to analyse the presence of PM extract in cosmetic products based on the 
detection of puerarin after successive extraction via methanolic sonication 








Pueraria mirifica (PM) or P. candollei var. mirifica is 
a plant can be found in northern Thailand and belongs 
to the Leguminosae family. The tubers of PM have been 
consumed by native Thai for generations to relieve post-
menopausal symptoms including skin wrinkle, hair and 
memory losses [1,2]. Many scientific studies have proven 
the pharmacological activities such as estrogenic [3,4], 
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antioxidant [5], antioesteroporosis [6,7], anticancer [8], anti-
mutagenic [9], neuroprotective [10], antidiabetic [11] of PM 
extracts. Few clinical studies proved that the administra-
tion of PM would promote the reduction of low-density 
lipoprotein [12-14].
Researchers revealed that the predominant phytochem-
icals in PM are isoflavones or commonly known as phy-
toestrogens. This is because isoflavones have structural 
similarities to estrogens with the hydroxyl groups at the 
C7 and C4 positions as estradiol molecule which could 
bind to estrogen receptors. Puerarin (8-C-glucoside of 
daidzein) accounts for about half of the total isoflavone 
content together with other small amount of isoflavones 
such as genistin (7-O-glucoside of genistein) and daid-
zin (7-O-glucoside of daidzein). Puerarin is a marker 
compound of the Pueraria genus [15]. It is a heat sensitive 
compound and temperature may change the composition 
of isoflavone conjugates [16]. Possibly, isoflavones may be 
altered after an extended period of storage even at room 
temperature [17]. 
The administration of PM extract at 20-100 mg/day for 
6 months, or 100-200 mg/day for 12 months was found to 
relieve menopause symptoms without significant changes 
on hepatic, hematologic, and renal functions [1]. A recom-
mended safe dose of PM supplement was 1-2 mg/kg body 
weight/day or about 50-100 mg/day [1]. However, the long-
term effect of administration has not yet been clarified in 
detail. PM has yet to obtain regulatory approval as a di-
etary ingredient in Australia, Singapore, United States and 
European countries due to the lack of safety assessment. 
In the present study, the phytochemicals of PM tuber 
were analyzed and compared between its flesh and peel 
extracts. Maceration was performed to extract phytochem-
icals from the PM tuber to avoid thermal degradation of 
isoflavones. A successive extraction by methanol and ethyl 
acetate was introduced to recover puerarin from the highly 
complex mixture of cosmetic products. The presence of 
puerarin was confirmed using liquid chromatography tan-
dem mass spectrometry.
2. Methodology
2.1 Chemical and Products
The tuber of PM was purchased from the province of 
Phatthalung, Thailand. The standard chemical, puerarin 
(≥ 98 %) was purchased from Sigma-Aldrich (St. Lou-
is, USA). Three cosmetic creams containing P. mirifica 
extract were purchased from different regions of local 
markets in Malaysia. Product A has low viscosity and yel-
lowish cream, whereas Product B and C were white and 
smooth cream. 
2.2 Maceration of P. mirifica 
The tuber of P. mirifica was cleaned and peeled before 
sliced into thin and small pieces. Both flesh slices and 
peel were put on trays for oven drying at 65°C for 3 days 
until completely dryness. The dried samples were ground 
into powder. Ten grams of samples was macerated in 200 
mL methanol (95%) in two different flasks for 5 days. The 
flasks were swirled on a daily basis and loosened the caps 
for gas release. The supernatant was decanted, filtered and 
evaporated to dryness using a rotary evaporator (Heidolph, 
Laborota 4003, Germany). The dried extracts were kept in 
a refrigerator for subsequent antiradical and LC-MS/MS 
analyses (Figure 1).
Figure 1. Flow diagram of sample preparation, extraction 
and analyses for P. mirifica tuber
2.3 Puerarin Extraction from Commercial Prod-
ucts
One gram of product creams was weighted and mixed 
with 5 mL methanol in individual tubes (10 mL). The 
tubes were vortexed for 1 min and sonicated for 10 min 
using an ultrasonic bath (Daihan Scientific, South Korea, 
50 kHz, 400W) at 30 oC. The mixture was then centri-
fuged at 6000 rpm for 60 min. The supernatant was de-
canted and filtered into ceramic evaporating dishes for 
drying in an oven at 65 oC. 
The dried extracts were re-constituted in 5% methanol 
(20 mL) and poured into a separating funnel (100 mL). 
Ethyl acetate (30 mL) was added into the funnel and the 
mixture was vigorously shaked for 5 min. Generated gas 
during extraction was released from the funnel from time 
to time. The mixture was left to separate into 2 significant 
DOI: https://doi.org/10.30564/jim.v10i1.3287
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layers. Ethyl acetate which was located at the top layer 
was withdrawn. Another fresh ethyl acetate (20 mL) was 
added into the remaining aqueous solution for extraction 
again. The process was repeated for thrice and the col-
lected ethyl acetate was combined for drying. The dried 
product extract was kept in a fridge at 4 oC for subsequent 
analysis.
2.4 Determination of Puerarin Recovery
The performance of puerarin extraction from commer-
cial products was determined by spiking a known concen-
tration of standard puerarin into products. One gram of 
product creams was taken and put into individual tubes. A 
1 mL of puerarin (10 mg/L) was spiked into the individual 
tubes. The tubes were then topped up with methanol to 5 
mL. The tubes were then well mixed for 1 min, sonicated 
for 10 min and centrifuged to harvest the supernatant as 
explained in the procedures of puerarin extraction from 
commercial products. The harvested supernatant was oven 
dried. The experiments without the procedure of puerarin 
spiking were performed as control (unspiked). The dried 
weights of product extracts were recorded for unspiked 
and spiked experiments. 
Subsequently, the dried product extracts were re-consti-
tuted in 5% methanol (20 mL) and subjected to liquid-liq-
uid chromatography using ethyl acetate as solvent for 
puerarin recovery. The combined ethyl acetate (60 mL) 
was dried and then re-constituted in methanol for LC-MS/
MS analysis. The recovery of puerarin was determined 
using Equation (1). 
Recovery (%) =      (1)
[P]0: Puerarin concentration in unspiked product extract 
(mg/L)
[P]1: Puerarin concentration in spiked product extract 
(mg/L)
[Pspiked]: Spiked concentration (2 mg/L)
2.5 LC-MS/MS for Puerarin 
A hyphenated system consisted of ultra-high perfor-
mance liquid chromatography (Waters Acquity UPLC; 
Milford, MA) and a triple quadrupole and linear-ion trap 
mass spectrometer (AB SCIEX 4000 QTRAP; Foster City, 
CA) was used to determine the concentration of puerarin. 
The strong wash and weak wash solution of the system 
were 10 and 50% of acetonitrile, respectively. The gra-
dient of mobile phase consisted of solvent A (water with 
0.1% formic acid) and solvent B (acetonitrile) was: 0-5 
min, 10% B; 5-15 min, 10-80% B; 15-20 min, 80% B; 20-
25 min, 80-10% B; 25-30 min, 10% B for final washing. 
The separation was carried out in a C18 reversed phase 
Acquity column (4.6 x 100 mm, 1.7 μm). The flow rate 
was 0.25 mL/min and the injection volume was 5 μL. 
The presence of puerarin was detected using the scan 
mode of enhanced product ion. The fragmentation pattern 
was matched to the product ions generated by standard 
puerarin. Untargeted mass screening was performed by 
the scan mode of enhanced mass spectra (EMS) linked 
to information dependent acquisition (IDA) with two 
parallel modes of enhanced product ion (EPI) at different 
collision energies ranged from 10 to 40 V. The capillary of 
ion source was maintained at 400 oC. The voltage was set 
at 5.0 kV and 4.5 kV for positive and negative ion modes, 
respectively. Nitrogen was used as ion source gas for neb-
ulization, 40 psi; for drying solvent, 40 psi; curtain gas, 10 
psi; collision gas, high; declustering potential, 40 V, and 
collision exit energy, 10 V. The scan rate was 1000 amu/s. 
A serial dilution of puerarin standard solution ranged from 
0.5 to 10 ppm was prepared for the construction of cali-
bration curve. Sample was filtered with nylon membrane 
filter (0.22 μm) before injection.
2.6 Antiradical Assay 
The radical scavenging activity of samples was deter-
mined using DPPH (1,1-diphenyl-2-picrylhydrazyl) assay. 
A 3.5 mL methanolic DPPH (0.1 mM) was added into 
0.5 mL sample with different concentrations. The solu-
tion was incubated for 30 min and the absorbance of the 
solution was measured using a UV-Vis spectrophotometer 
(Shimadzu UV-1800, Tokyo, Japan) at 517 nm. The DPPH 
reagent added with methanol only was used as blank. The 
inhibition of samples was calculated from Equation (2). 
The inhibition at 50% (EC50) explains the effective con-
centration of samples to inhibit 50% free radicals generat-
ed from the assay. 
Inhibition (%) =  × 100      (2)
Where Ab = absorbance of blank,
As = absorbance of sample or standard 
3. Results and Discussion
3.1. Pueraria Mirifica Tuber Extract and Its Anti-
oxidant Capacity
Maceration was conducted for the flesh and peel of PM 
tuber. The results found to produce yellowish and brown 
extracts from the flesh and peel samples, respectively. 
Higher yield of extract (9.4 %) was obtained from the peel 
samples which also exhibited higher radical scavenging 
activity (Table 1). As a comparison, the EC50 of peel ex-
DOI: https://doi.org/10.30564/jim.v10i1.3287
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tract was about four times higher than the flesh extract. 
This was because the higher amount of flesh extract was 
required to achieve EC50 (7.4303 mg/mL) than that of 
the peel extract (1.8636 mg/mL). In another word, the 
antioxidant capacity was about 57.7 % per milligram of 
peel extract as observed from the concentration dependent 
inhibitory curve. This value was about four times higher 
than that of flesh extract (15.6 % per milligram of flesh 
extract). The result was in good agreement with the find-
ings of Zhang et al. [18] who reported higher free radical 
scavenging activity exhibited by the outer bark of Puer-
aria lobata roots. The total inhibition of DPPH radicals 
can be seen at 8 mg/mL of peel extract, whereas only 60% 
of inhibition was exhibited by flesh extract at the similar 
concentration (Figure 2). The antioxidant capacity of PM 
tuber was found to be lower than that of Pueraria thun-
bergiana Benth (16.4 μg/mL) as reported by Son et al. [19]. 
The researchers reported that higher antioxidant capacity 
could be due to the high total phenolic and isoflavone con-
tent. Many bioactivities reported for the genus Pueraria 
were attributed to isoflavone glycosides, mainly puerarin 
[15]. Table 1 shows the peel extract possessed higher con-
centration of puerarin (4.6553 mg/g extract) which was 
about four times higher than the flesh extract (1.0731 mg/
g extract).
Table 1. Yield and antioxidant capacity of Pueraria mirifi-








Tuber flesh Yellowish 7.1 ± 0.9 1.073080863 7.4303
Tuber peel brown 9.4 ± 1.8 4.655276066 1.8636
3.2 LC-MS/MS Detection of Pueraria Mirifica Tu-
ber Extract
In the subsequent experiments, both flesh and peel 
extracts were subjected to LC-MS/MS analysis. The frag-
ment ions of puerarin in both negative and positive ion 
modes are presented in Figure 3. The characteristic ions 
of m/z 297 and m/z 267 as reported by Li et al. [20] were 
also detected in this study. The peak width of puerarin was 
found to be narrower at the negative ion mode (0.2 min) 
than that of positive ion mode (0.5 min) at 0.5 % peak 
height. A narrow peak width is always better for peak res-
olution, even though MS detector does not have difficulty 
in compound identification with overlaped peaks. Further-
more, the signal to noise ratio of puerarin was higher at 
the negative ion mode (30) than that of positive ion mode 
(10.7). Both calibration curves showed to have a good lin-
earity in the range of 0.5 to 10 mg/L with the coefficient 
correlation of 0.9980 and 0.9563 at the negative and posi-
tive ion modes, respectively.
The untargeted mass screening also found to detect 
many flavonoids, especially isoflavones from PM tuber 
(Table 2). The detected compounds have mostly higher 
content in peel extract. In line with the findings of Cheng 
et al. [21], the outer bark of PM tuber also contained higher 
isoflavonoids. This also explains peel extract exhibited 
higher antioxidant capacity due to the presence of isofla-
vones.
3.3 Recovery of Puerarin from Cosmetic Products
Since the wide application of PM in cosmetic formula-
tion, three commercial cosmetic creams with PM extract 
as one of the major ingredients was purchased from the lo-
cal markets of Malaysia. They were extracted by methanol 
and then back extraction by ethyl acetate using the tech-
nique of liquid-liquid extraction. The yield of methanolic 
Figure 2. The inhibitory curves of (a) flesh and (b) peel extracts in a concentratuion dependent manner
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Figure 3. Total ion chromatograms (a and b) and mass spectra of puerarin (c and d) detected at the negative (c) and 
positive (d) ion modes
DOI: https://doi.org/10.30564/jim.v10i1.3287
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Table 2. Compounds detected at negative and positive modes in the flesh and peel extracts of Pueraria mirifica tuber
Rt (min) Negative ion (m/z) Fragment ions Compound Flesh Peel Reference
2.33 133 133/115 malic acid 1.58E+09 1.19E+09 [22]
7.50 253 223/207/195/180/155/135/133 diadzein 1.23E+09 1.76E+09 [23]
8.64 269 269/224/180/159 apigenin 6.19E+08 9.18E+08 [24]
14.30 271 271/253/225 naringenin 3.54E+08 1.06E+08 [25]
11.71 339 339/324/281/253/241/183 glyceollidin 0 1.16E+09 [26]
4.26 415 415/307/297/267bp/253/209 puerarin 1.36E+09 1.48E+09 Standard
3.89 431 431/311/283/255/227/211 vitexin (apigenin-8-C-glucoside) 0 1.03E+09 [24]
4.67 445 445/325/282/254/225 glycitin 0 8.29E+08 [26]
4.99 563 563/323/311/283/239 apigenin-6,8-C-pentoside-hexoside 8.75E+07 1.42E+09 [27]
3.37 577 577/457/294/266/222 puerarin glycoside 0 5.60E+08 [28]
5.28 611 611/564/269bp apigenin diglucoside 1.02E+09 1.42E+09 [29]
Rt (min) Positive ion (m/z)  Compound Flesh Peel Reference
7.26 255 255/199/227/137 daidzein 7.83E+08 1.42E+09 [28]
5.12 255 255/237(-18)/227(-28)/199(-28-28)/137 dihydroxyflavone 2.39E+08 7.98E+08 [29]
8.60 271 271/197/153 apigenin 2.59E+08 0.00E+00 [29]
7.50 285 285/270/229/213/139 calycosin 0 5.49E+08 [29]
8.96 301 301/286/283/240/187/123 pratensein 0 5.45E+08 [29]
6.40 315 315/297/287/237/209/137 dihydroxy-dimethoxyisoflavone 0 3.07E+08 [29]
4.26 417 417/307/297/267bp/163 puerarin (daidzin 8-C-glucoside) 1.25E+09 2.60E+09 Standard 
3.67 433 433/397/367/313/283/267/255/165 3′-hydroxy-puerarin 0 1.45E+09 [30]
5.15 433 433/397/367/313/283/267/255/165 3′-hydroxy-puerarin (isomer) 7.66E+08 1.64E+09 [30]
4.52 447 447/351/327/297/269/255/165/ apigenin C-glucuronide 0 1.64E+09 [30]
4.00 549 549/417/307/297/267 puerarin pentoside 4.25E+08 2.76E+09 [28]
3.32 579 579/417/307/297/267bp/239 puerarin glycoside 1.66E+08 1.23E+09 [28]
1.96 579 579/417/307/297/267bp/239 puerarin glucoside isomer 0 7.41E+08 [28]
4.10 579 579/447/429/393/381/327/297/269 swertisin pentoside 0 8.76E+08 [31]
Table 3. Puerarin content in cosmetic products and their radical scavenging activity
Product Yield of methanolic extract (%)
Yield of ethyl acetate 
extract (%) Puerarin (µg/mL) DPPH (%)
Puerarin recovery from spiked 
experiments (%)
A 2.8 ± 0.7 20.6 ± 7.7 0.3095 ± 0.0254 32.1 ± 2.4 115.8
B 3.8 ± 0.6 32.4 ± 9.8 0.4353 ± 0.0341 3.1 ± 0.01 96.0
C 5.6 ± 0.6 38.1 ± 8.2 0.5255 ± 0.0309 4.4 ± 0.4 89.1
DOI: https://doi.org/10.30564/jim.v10i1.3287
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and ethyl acetate extract, as well as the recovered puerarin 
concentration are listed in Table 3. Lipophilic puerarin 
could be partitioned and recovered from the complex aqu-
oues mixture into the organic phase of ethyl acetate [32]. It 
was found that the concentration of puerarin was ranged 
between 0.3095 to 0.5255 µg/mL (Table 3). The measured 
radical scavenging activity was varied from 3.1 % to 32.1 
% independent on the detected concentration of puerarin 
in the products. This was because the cosmetic products 
contained a mixture of plant extracts which might be ex-
tracted out together with puerarin, and thus contributing to 
the synergistic antioxidant capacity. 
A spiked experiment was also conducted to reveal 
the performance of puerarin extraction from commercial 
cosmetic products. Puerarin could be recovered from the 
highly complex product mixture effectively (Table 3). A 
good recovery ranged from 89.1 % to 115.8%, was ob-
tained for puerarin. The results revealed that the recovery 
of puerarin was strongly affected by the texture of sample 
matrices. Products with thick or liquidified texture should 
be well homogenized prior to analyses.
4. Conclusions
The concentration of puerarin was found to be about 4 
times higher in the peel extract of PM tuber than its flesh 
extract. The higher concentration puerarin in the peel ex-
tract was also showed to have higher radical scavenging 
activity. The detection which was performed by a triple 
quadrupole mass analyser exhibited better identification 
power at the negative ion mode. Successive extraction 
by methanolic sonication and ethyl acetate partition was 
found to be effective in recovering puerarin from the high-
ly complex cosmetic products.
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